PET Imaging of Tau Deposition in the Aging Human Brain - Estadísticas de Google Académico

Artículos que citan PET Imaging of Tau Deposition in the Aging Human Brain

Título / Autor	Año
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, B Dunn, SB Haeberlein, ... Alzheimer's & Dementia 14 (4), 535-562	2018
A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers CR Jack, DA Bennett, K Blennow, MC Carrillo, HH Feldman, GB Frisoni, ... Neurology 87 (5), 539-547	2016
Tau and tauopathies T Arendt, JT Stieler, M Holzer Brain research bulletin 126, 238-292	2016
The road to restoring neural circuits for the treatment of Alzheimer's disease RG Canter, J Penney, LH Tsai Nature 539 (7628), 187	2016
Defining imaging biomarker cut points for brain aging and Alzheimer's disease CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, VJ Lowe, DS Knopman, ... Alzheimer's & Dementia 13 (3), 205-216	2017
Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease? BA Mander, JR Winer, WJ Jagust, MP Walker Trends in neurosciences 39 (8), 552-566	2016
Tau PET imaging: present and future directions L Saint-Aubert, L Lemoine, K Chiotis, A Leuzy, E Rodriguez-Vieitez, ... Molecular neurodegeneration 12 (1), 19	2017
Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between β-amyloid and tauopathy L Wang, TL Benzinger, Y Su, J Christensen, K Friedrichsen, P Aldea, ... JAMA neurology 73 (9), 1070-1077	2016
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy L Passamonti, P Vázquez Rodríguez, YT Hong, KSJ Allinson, ... Brain 140 (3), 781-791	2017
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition MJ Pontecorvo, MD Devous Sr, M Navitsky, M Lu, S Salloway, FW Schaerf, ... Brain 140 (3), 748-763	2017
Propagation of tau aggregates and neurodegeneration M Goedert, DS Eisenberg, RA Crowther Annual review of neuroscience 40, 189-210	2017
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers R Smith, A Puschmann, M Schöll, T Ohlsson, J Van Swieten, M Honer, ... Brain 139 (9), 2372-2379	2016
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions VL Villemagne, V Doré, SC Burnham, CL Masters, CC Rowe Nature Reviews Neurology 14 (4), 225	2018
In vivo tau, amyloid, and gray matter profiles in the aging brain J Sepulcre, AP Schultz, M Sabuncu, T Gomez-Isla, J Chhatwal, A Becker, ... Journal of Neuroscience 36 (28), 7364-7374	2016
Tau positron emission tomographic imaging in the Lewy body diseases SN Gomperts, JJ Locascio, SJ Makaretz, A Schultz, C Caso, N Vasdev, ... JAMA neurology 73 (11), 1334-1341	2016
Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies M Marquié, MD Normandin, AC Meltzer, M Siao Tick Chong, NV Andrea, ... Annals of neurology 81 (1), 117-128	2017
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, DS Knopman, V Lowe, ... The Lancet Neurology 16 (6), 435-444	2017
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease A Bejanin, DR Schonhaut, R La Joie, JH Kramer, SL Baker, N Sosa, ... Brain 140 (12), 3286-3300	2017
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease A Maass, S Landau, SL Baker, A Horng, SN Lockhart, R La Joie, ... Neuroimage 157, 448-463	2017
[18F] AV‐1451 tau positron emission tomography in progressive supranuclear palsy JL Whitwell, VJ Lowe, N Tosakulwong, SD Weigand, ML Senjem, ... Movement Disorders 32 (1), 124-133	2017

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.